Design and Synthesis of 1,4-dihydropyridine Derivatives as Anti-cancer Agent

Area of Science:

• Medicinal Chemistry
• Oncology
• Drug Discovery

Background:

• 1,4-dihydropyridine derivatives are a class of compounds with diverse biological activities.
• Cancer remains a significant global health challenge, necessitating the development of novel therapeutic agents.

Purpose of the Study:

• To design and synthesize novel 1,4-dihydropyridine-based compounds incorporating a benzylpyridinium moiety.
• To evaluate the in vitro anticancer activity of these synthesized compounds against various human cancer cell lines.

Main Methods:

• Synthesis of a series of 1,4-dihydropyridine derivatives.
• In vitro anticancer activity assessment using the MTT assay.
• Cytotoxicity evaluation against glioblastoma (U87MG), lung cancer (A549), and colorectal adenocarcinoma (Caco-2) cell lines.
• Comparison of synthesized compounds' efficacy with standard chemotherapeutic drugs (carboplatin, gemcitabine, daunorubicin).

Main Results:

• Compounds 7b, 7d, 7e, and 7f demonstrated significant and potent anticancer activity across the tested cancer cell lines.
• The synthesized 1,4-dihydropyridine derivatives exhibited promising cytotoxic effects.

Conclusions:

• The designed 1,4-dihydropyridine compounds, particularly 7b, 7d, 7e, and 7f, represent encouraging candidates for further investigation.
• These compounds hold potential for development into novel anticancer agents for glioblastoma, lung, and colorectal cancers.